Auvi-q Injection, Solution
NDC Package 51662-1663-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Auvi-q injection is a medication used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. This formulation utilizes a injection, solution delivery system. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1663 and is authorized under FDA application NDA201739.

Identification & Billing

NDC Package Code
51662-1663-2
Package Description
2 DOSE PACK in 1 CARTON / .3 mL in 1 DOSE PACK (51662-1663-1)
Product Code
11-Digit Billing Format
51662166302
RxNorm Crosswalk
  • RxCUI: 1870205 - EPINEPHrine (generic for Auvi-Q) 0.3 MG in 0.3 ML Auto-Injector
  • RxCUI: 1870205 - NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector
  • RxCUI: 1870205 - epinephrine (generic for Auvi-Q) 0.3 MG per 0.3 ML Auto-Injector

Clinical Specifications

Proprietary Name
Auvi-q
Non-Proprietary Name
Auvi-q
Substance Name
Epinephrine
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
Usage Information
This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
Product Type
Human Prescription Drug
FDA Application #
NDA201739
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-15-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1663-2 identifies a specific commercial package of 2 dose pack in 1 carton / .3 ml in 1 dose pack (51662-1663-1) of Auvi-q, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. This injection, solution is formulated for intramuscular use and contains epinephrine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on November 15, 2012. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used in emergencies to treat very serious allergic reactions to insect stings/bites, foods, drugs, or other substances. Epinephrine acts quickly to improve breathing, stimulate the heart, raise a dropping blood pressure, reverse hives, and reduce swelling of the face, lips, and throat.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662166302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1663-2
11-Digit CMS (5-4-2)
51662-1663-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.